Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study-Reference-Cited by-同舟云学术

Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study

Published:2020-07-30 Issue:1 Volume:35 Page:123-134
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J. Eur. Acad. Dermatol. Venereol.

Author:

Augustin M.¹^ORCID,Kleyn C.E.²,Conrad C.³,Sator P.G.⁴,Ståhle M.⁵,Eyerich K.⁶,Radtke M.A.⁷,Bundy C.⁸,Mellars L.⁹,Greggio C.¹⁰,Cordey M.¹¹,Koscielny V.¹⁰,Griffiths C.E.M.²

Affiliation:

1. Institute for Health Services Research in Dermatology and Nursing University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. The Dermatology Centre The University of ManchesterNIHR Manchester Biomedical Research Centre Manchester UK

3. Service of Dermatology and Venereology Centre Hospitalier Universitaire Vaudois Lausanne Switzerland

4. Department of Dermatology Hietzing Hospital Vienna Austria

5. Unit of Dermatology Department of Medicine Karolinska Institutet Stockholm Sweden

6. Department of Dermatology and Allergy Technical University of Munich Munich Germany

7. Dermatologikum Hamburg Hamburg Germany

8. College of Biomedical and Health Sciences Cardiff University Cardiff UK

9. Celgene Corporation Summit NJ USA

10. Celgene International Boudry Switzerland

11. Amgen Europe GmbH Rotkreuz Switzerland

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16431

Reference45 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. Prevalence of cardiovascular risk factors in patients with psoriasis

3. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

4. Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry

5. Cytokines in psoriasis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence, persistence and treatment switching in psoriasis;Immunotherapy;2024-04-23

2. Use of Apremilast to Achieve Psoriatic Arthritis Treatment Goals and Satisfaction at 1 Year in the Canadian Real-World APPRAISE Study;Rheumatology and Therapy;2024-02-28

3. Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands;Advances in Therapy;2024-02-24

4. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice;Journal of the European Academy of Dermatology and Venereology;2023-06-13

5. Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study;JEADV Clinical Practice;2023-05-24